SCHEMBL10154536

SCHEMBL10154536

Cc1ccc(C2(C)CCSC(N)=N2)cc1F

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.58
KCNH2 Q12809 1/20 0.51
BACE2 Q9Y5Z0 2/20 0.47
CTSD P07339 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10155523 0.83 BACE1 (0.64) BACE1KCNH2BACE2CTSD
SCHEMBL1422474 0.82 BACE1 (0.57) BACE1KCNH2BACE2CTSD
SCHEMBL1422468 0.82 BACE1 (0.57) BACE1KCNH2BACE2CTSD
Hydrochloric Acid SCHEMBL17004594 0.81 BACE1 (0.56) BACE1KCNH2BACE2CTSD
Hydrochloric Acid SCHEMBL17004596 0.81 BACE1 (0.56) BACE1KCNH2BACE2CTSD
SCHEMBL10154711 0.81 BACE1 (0.65) BACE1
SCHEMBL10155508 0.81 BACE1 (0.71) BACE1KCNH2BACE2CTSD
SCHEMBL10155310 0.80 BACE1 (0.63) BACE1BACE2
SCHEMBL10154533 0.79 BACE1 (0.73) BACE1KCNH2
SCHEMBL10154637 0.78 BACE1 (0.70) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150210680-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO (JP) 2015-07-30 US disclosed
US-9029358-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2015-05-12 US disclosed
US-8895548-B2 Pharmaceutical composition for treating alzheimer's disease SHIONOGI & CO., LTD. (JP) 2014-11-25 US disclosed
US-8815851-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2014-08-26 US disclosed
US-20140058097-A1 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE SHIONOGI & CO., LTD. (JP) 2014-02-27 US disclosed
US-8633188-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2014-01-21 US disclosed
US-20130303755-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO (JP) 2013-11-14 US disclosed
US-8546380-B2 Aminodihydrothiazine derivatives SHIONOGI & CO., LTD. (JP) 2013-10-01 US disclosed
US-20130158260-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2013-06-20 US disclosed
US-20120022249-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2012-01-26 US disclosed
US-20120016116-A1 AMINODIHYDROTHIAZINE DERIVATIVES SHIONOGI & CO., LTD. (JP) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016116-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP BACE1 1/4885KCNH2 2842/4885BACE2 2/4885
US-20130158260-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP BACE1 1/4885KCNH2 2713/4885BACE2 2/4885
US-20140058097-A1 PHARMACEUTICAL COMPOSITION FOR TREATING ALZHEIMER'S DISEASE NR1H2, NR1H3, NR0B1 BACE1 17/4885KCNH2 2155/4885BACE2 135/4885
US-20130303755-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP BACE1 1/4885KCNH2 2842/4885BACE2 2/4885
US-20120022249-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP BACE1 1/4885KCNH2 2842/4885BACE2 2/4885
US-20150210680-A1 AMINODIHYDROTHIAZINE DERIVATIVES BACE1, BACE2, APP BACE1 1/4885KCNH2 2842/4885BACE2 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.